ASX:OSL - US FDA HDE and TRIPP-FFX Study Presentation

ASX:OSL

Company

Our People Corporate Governance

Announcements

ASX Announcements Market Data Financial Reports Investor Presentations

Back to OncoSil Medical

US FDA HDE and TRIPP-FFX Study Presentation

Your question will be sent privately to OncoSil Medical Ltd. The company may choose to make this question public.

Start the conversation

Ask OncoSil Medical Ltd a question about this announcement.

Share your feedback

Discover